Clarify Clinics
Clarify Clinics offers the Clari Procedure, an elective plasma adsorption treatment that selectively removes environmental toxins, microplastics, PFAS, and metabolic waste from the bloodstream while preserving essential plasma components. The two-hour outpatient procedure uses the CE-marked MTx.100 column with 200,000m² of adsorptive surface area, and includes pre- and post-treatment laboratory testing to quantify microplastic reduction.
- Healthcare Technology
- Medical Devices
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Accumulated environmental toxins, microplastics, PFAS, and metabolic waste circulate in human plasma and contribute to inflammation, oxidative stress, and rising toxic burden. Conventional detoxification methods are non-selective, and there is limited clinical access to procedures that can remove these substances from the bloodstream without also stripping essential plasma components.
Solution
Clarify Clinics provides the Clari Procedure, an elective plasma adsorption treatment branded as "Subtractive Medicine," that selectively removes harmful substances from the bloodstream while retaining vital components. The procedure routes plasma through the MTx.100 column, which uses a patented blend of adsorptive media with 200,000m² of surface area to capture toxins, drug overdoses, and endocrine disruptors. Unlike therapeutic plasma exchange, Clari returns the patient's own cleaned plasma rather than replacing it with donor albumin and saline. The procedure takes about two hours, is generally well-tolerated, and most patients resume normal activities the same day. Clarify Clinics also offers advanced laboratory testing before and after the procedure to measure circulating microplastics and quantify reduction.
Target Audience
Primary customers are individuals seeking elective reduction of circulating environmental toxins and metabolic waste, including those concerned about microplastic exposure, PFAS accumulation, or long-COVID symptoms, as well as clinicians offering advanced detoxification services.
Features
- MTx.100 adsorption column with 200,000m² of surface area, equivalent to 37 American football fields, enabling high-capacity toxin binding
- Selective removal of microplastics (≥5 microns), PFAS, paraquat, endocrine disruptors, drug overdoses, and metabolic waste from plasma
- Retention of antibodies, electrolytes, albumin, coagulation factors, and cell signaling molecules to preserve immune and metabolic stability
- CE-marked medical device developed by Marker, with procedures performed at Clarify Clinics as a joint venture
- Pre- and post-procedure laboratory testing to quantify baseline and post-treatment microplastic burden
- Two-hour outpatient procedure with same-day recovery and reported improvements in sleep, mental clarity, and energy